Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROCAMIO: Amiodarone vs Procainamide in Wide QRS Tachycardia
NCT00383799Phase 4Terminated
- Sponsor
- Gregorio Marañón University General Hospital
- Start
- Sep 2005
- Primary completion
- Jun 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of amiodarone in ventricular tachycardia (VT) (2 arms), sponsored by Gregorio Marañón University General Hospital. Primary endpoint: Clinically significant cardiac adverse events at 40 minutes. Started Sep 2005; status: terminated.
02
Drugs
amiodarone
03
Conditions
ventricular tachycardia (VT)
Beyond the preview
Go deeper on NCT00383799.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00383799.